Opinion: STAT+: CVS’ split doesn’t fix its fundamental problem

PBMs are still benefiting off the backs of average Americans Andres Kudacki/Getty Images CVS Health is one of the largest companies in the U.S. It serves the health care needs of hundreds of millions of Americans annually, has a hand in nearly every part of the drug supply chain, and has more than $400 billion in annual revenue. So when it announced last Wednesday that it will split into two entities, the news made waves. Here’s the thing: Much of the media coverage frames this move as CVS unwinding its vertical integration in response to ongoing regulatory pressure. That is not what is happening here. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe